Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Nutr J ; 14: 45, 2015 May 09.
Artigo em Inglês | MEDLINE | ID: mdl-25956387

RESUMO

INTRODUCTION: An issue of recent research interest is excessive stoma output and its relation to electrolyte abnormalities. Some studies have identified this as a precursor of dehydration and renal dysfunction. A prospective study was performed of the complications associated with high-output stomas, to identify their causes, consequences and management. MATERIALS AND METHODS: This study was carried out by a multidisciplinary team of surgeons, gastroenterologists, nutritionists and hospital pharmacists. High-output stoma (HOS) was defined as output ≥1500 ml for two consecutive days. The subjects included in the study population, 43 patients with a new permanent or temporary stoma, were classified according to the time of HOS onset as early HOS (<3 weeks after initial surgery) or late HOS (≥3 weeks after surgery). Circumstances permitting, a specific protocol for response to HOS was applied. Each patient was followed up until the fourth month after surgery. RESULTS: Early HOS was observed in 7 (16%) of the sample population of 43 hospital patients, and late HOS, in 6 of the 37 (16%) non-early HOS population. By type of stoma, nearly all HOS cases affected ileostomy, rather than colostomy, patients. The patients with early HOS remained in hospital for 18 days post surgery, significantly longer than those with no HOS (12 days). The protocol was applied to the majority of EHOS patients and achieved 100% effectiveness. 50% of readmissions were due to altered electrolyte balance. Hypomagnesaemia was observed in 33% of the late HOS patients. CONCLUSION: The protocol developed at our hospital for the detection and management of HOS effectively addresses possible long-term complications arising from poor nutritional status and chronic electrolyte alteration.


Assuntos
Estomas Cirúrgicos/efeitos adversos , Estomas Cirúrgicos/patologia , Idoso , Neoplasias Colorretais/sangue , Neoplasias Colorretais/dietoterapia , Neoplasias Colorretais/etiologia , Colostomia/métodos , Feminino , Humanos , Ileostomia/métodos , Deficiência de Magnésio/sangue , Deficiência de Magnésio/dietoterapia , Deficiência de Magnésio/etiologia , Masculino , Desnutrição/sangue , Desnutrição/dietoterapia , Desnutrição/etiologia , Pessoa de Meia-Idade , Estado Nutricional , Complicações Pós-Operatórias/sangue , Complicações Pós-Operatórias/dietoterapia , Complicações Pós-Operatórias/etiologia , Estudos Prospectivos
2.
Obes Surg ; 27(5): 1222-1228, 2017 05.
Artigo em Inglês | MEDLINE | ID: mdl-27864670

RESUMO

BACKGROUND: Vitamin D deficiency (VDD) is associated with obesity and metabolic syndrome (MS). After bariatric surgery (BS), high rates of VDD often persist and some patients are refractory to the resolution of comorbidities. The aim of the present study is to analyse the relationship between the levels of vitamin D and the persistence of MS components at 12 months after BS, according to the surgical technique used. METHODS: We performed a retrospective study of 46 patients undergoing BS: 23 underwent laparoscopic Roux-en-Y gastric bypass (LRYGBP) and 23 laparoscopic sleeve gastrectomy (LSG). These patients had an average BMI of 45 kg/m2 (34-63). Levels of vitamin D were classified as deficient (<20 ng/dl), insufficient (20-30 ng/dl) or normal (>30 ng/dl) and analysed in relation to the components of MS (high blood pressure (HBP), dyslipidaemia (DL) and type 2 diabetes mellitus (T2DM) preoperatively and 12 months after surgery. RESULTS: VDD was observed in 77% of the patients prior to surgery. There were no significant associations between predisposing factors and baseline vitamin D. After surgery, plasma levels of vitamin D increased in both groups, but only 18% of the patients achieved normal values. Both groups had achieved significant improvements in MS components. Thus, 63% of all the patients achieved complete resolution of HBP, 54% that of DL and 77% that of T2DM. Moreover, MS was present in 11% of the patients, compared to 63% at baseline, and the MS resolution rate was 83%, with no significant differences between LRYGBP and LSG. CONCLUSIONS: There is a relationship between VDD and persistence of MS, and particularly so with T2DM. VDD could represent a predictor of MS persistence at 12 months after surgery.


Assuntos
Gastrectomia , Derivação Gástrica , Síndrome Metabólica/epidemiologia , Obesidade Mórbida/cirurgia , Deficiência de Vitamina D/epidemiologia , Adulto , Comorbidade , Diabetes Mellitus Tipo 2/epidemiologia , Dislipidemias/epidemiologia , Feminino , Humanos , Hipertensão/epidemiologia , Laparoscopia , Masculino , Síndrome Metabólica/complicações , Pessoa de Meia-Idade , Obesidade Mórbida/epidemiologia , Estudos Retrospectivos , Deficiência de Vitamina D/complicações , Adulto Jovem
3.
Nutr Hosp ; 33(1): 43-46, 2016 Feb 16.
Artigo em Inglês | MEDLINE | ID: mdl-27019241

RESUMO

Aim: The aim of this study was to assess the prevalence of hypovitaminosis D in candidates to bariatric surgery (BS) and its relationship with risk factors and components of the metabolic syndrome. Material and methods: Clinical, anthropometric and biochemical parameters were measured in 56 Caucasian patients included in a protocol of BS between January and June 2014. Patients were stratified into three groups according to their vitamin D status: sufficiency (≥ 40 ng/ml), insufficiency (40-20 ng/ml) and deficiency (< 20 ng/ml). Results: Data showed vitamin D deficiency in 75% of patients. These patients had greater BMI (p = 0.006) and lower PTH concentrations in plasma (p = 0.045). In addition, there were more patients with diabetes mellitus type 2 (DM2) and dyslipidemia (DLPM) in the group with 25 (OH) D < 20 ng/ml levels. Another finding was that 25(OH) D levels were observed to be negatively correlated with fat mass (r = -0.504; p = 0.009), BMI (r = -0.394; p = 0.046) and hypertension (r = -0.637; p = 0.001). Conclusion: We conclude that vitamin D deficiency is extremely common among candidates to BS, who are associated with DM2 and DLPM. Although there are limited data regarding the best treatment for low Vitamin D status in BS candidate patients, screening for vitamin D deficiency should be regularly performed in cases of morbid obesity


Objetivo: el objetivo de este estudio fue evaluar la prevalencia de hipovitaminosis D en los candidatos a cirugía bariátrica (CB) y su relación con factores de riesgo y los componentes del síndrome metabólico. Material y métodos: los parámetros clínicos, antropométricos y bioquímicos se midieron en 56 pacientes caucásicos incluidos en un protocolo de cirugía bariátrica entre enero y junio de 2014. Los pacientes fueron estratificados en tres grupos de acuerdo al status de vitamina D: suficiencia (≥ 40 ng/ml), insuficiencia (40-20 ng/ml) y deficiencia (< 20 ng/ml). Resultados: se observó deficiencia de vitamina D en el 75% de los pacientes. Estos pacientes tenían mayor índice de masa corporal (p = 0,006) y concentraciones plasmáticas mas bajas de PTH (p = 0,045). Además, hubo más pacientes con diabetes mellitus tipo 2 (DM2) y dislipemia (DLPM) en el grupo con niveles de 25 (OH) D < 20 ng/ml. Asimismo la 25 (OH) D se correlacionó negativamente con la masa grasa (r = -0,504; p = 0,009), el IMC (r = -0,394; p = 0,046) y la hipertensión arterial (r = -0,637; p = 0,001). Conclusión: De nuestros hallazgos concluimos que la deficiencia de vitamina D es muy común entre los candidatos a CB y que la misma está asociada con DM2 y DLPM.Aunque hay pocos datos sobre el mejor tratamiento para el bajo nivel de vitamina D en los pacientes candidatos CB, la detección de la deficiencia de vitamina D debe realizarse de forma rutinaria en estos casos.


Assuntos
Cirurgia Bariátrica/métodos , Hidroxicolecalciferóis/sangue , Hidroxicolecalciferóis/deficiência , Síndrome Metabólica/sangue , Síndrome Metabólica/cirurgia , Deficiência de Vitamina D/sangue , Deficiência de Vitamina D/epidemiologia , Adulto , Índice de Massa Corporal , Diabetes Mellitus Tipo 2/complicações , Diabetes Mellitus Tipo 2/epidemiologia , Dislipidemias/complicações , Dislipidemias/epidemiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Hormônio Paratireóideo/sangue , Seleção de Pacientes , Espanha/epidemiologia
4.
Nutr Hosp ; 30(6): 1391-6, 2014 Dec 01.
Artigo em Espanhol | MEDLINE | ID: mdl-25433123

RESUMO

High output stoma is a frequent complication in patients with ileostomies that is not well identified and is not often properly addressed by clinicians. It has not been described properly, and can vary between debits of 2.000ml in 24 h to 1.500 ml in 3-5 days, according to different authors. Frequently presents both short-term and long-term negative implications for patients and is associated with readmissions. We present a review of published literature focusing in surgical resection-related factors that influence a later appearance of this complication, causes involved in its development, the need to establish a clear and objective concept of high ouput as well as the negative implications it presents. Also we develop how should we the management of these patients regarding treatment and nutritional approach.


La ostomía de alto débito es una complicación frecuente en pacientes portadores de ileostomías que está poco identificada y que no suele ser adecuadamente abordada desde el punto de vista clínico. No está descrita de manera consensuada, pudiendo variar entre débitos de 2.000 ml en 24h o alrededor de 1.500 ml en durante 3-5 días, según los autores. Suele presentar graves consecuencias para el paciente tanto a corto como a largo plazo y está asociada a reingresos. Se presenta una revisión de la literatura publicada al respecto sobre los factores relacionados con la resección quirúrgica que influyen en una posterior aparición de esta complicación, las causas que intervienen en su desarrollo, la necesidad de establecer un concepto objetivo y claro de alto débito así como las implicaciones negativas presenta. Así mismo se recoge como debe realizarse el manejo de estos pacientes con respecto al tratamiento y abordaje nutricional.


Assuntos
Ileostomia/efeitos adversos , Distúrbios Nutricionais/etiologia , Distúrbios Nutricionais/terapia , Apoio Nutricional/métodos , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/terapia , Humanos , Deficiência de Magnésio/etiologia , Deficiência de Magnésio/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA